Gasherbrum Bio, Inc., A Wholly Owned Subsidiary Of Structure Therapeutics

This study is testing whether a new medication called aleniglipron (GSBR-1290) can help people with obesity or overweight manage their weight when combined with diet and exercise. Researchers will compare the drug to a placebo in 82 participants over 44 weeks to see if it's safe …

This study is testing whether an experimental medication called aleniglipron can change body composition in people with obesity. 71 adults with a body mass index of 30 or higher will receive either the drug or a placebo for 40 weeks. Researchers will measure changes in body fat, …

This study is testing whether an experimental medication called aleniglipron helps people with obesity or overweight lose weight. About 220 participants will receive either the drug or a placebo for 36 weeks, with an option to continue for another 36 weeks. The main goal is to se…